Solentim, expert in cell therapy workflows enabling the creation, isolation and characterisation of high value cells, has launched two solutions to enhance the development of therapeutic antibodies. Icon is a benchtop system for the rapid stratification of high productivity clones and Studius is a proprietary software platform that delivers data on each cell’s journey through cell line development.
The all-in-one Icon system assesses specific productivity using rapid on-board assays for the three critical quality attributes of titer, cell number and cell viability. Using plate-based imaging for static plate cell counting and cell suspension automated cell counting with viability for fed-batch, Icon generates normalised cell productivity data. This information enables cell line development scientists to separate the promising clones from the rest, saving resources and accelerating workflows.
Studius is Solentim’s bespoke data management solution for cell line development. The over-arching platform is designed for Solentim’s instruments to provide control, management and reporting in the pursuit of lead candidates. Studius delivers a perspective on the journey of each individual cell, from seeding to selection, and intelligently manages verified information from multiple sources to enable scientists to select high value cells. It has been designed to protect data, providing data auditing and integrity with a suite of tools applicable for laboratories working under 21 CFR Part 11 compliance. Using the novel Historytree visualisation, Studius maps each cell’s journey, presenting all the necessary cell data for regulatory approval in one report.
